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Objectives: Periventricular leukomalacia is necrosis of the cerebral white matter
adjacent to the lateral ventricles and results from injury to immature oligodendro-
glia. In infants without congenital heart disease, periventricular leukomalacia is
associated with an increased incidence of developmental delay and attention deficit/
hyperactivity disorder. The incidence of periventricular leukomalacia and the risk
factors for development of periventricular leukomalacia after infant cardiac surgery
are not known.
Methods: Magnetic resonance imaging of the brain was performed 6 to 14 days after
cardiac surgery utilizing cardiopulmonary bypass with or without deep hypothermic
circulatory arrest in 105 neonates and infants  6 months of age.
Results: Median age at surgery was 6 days (range 1-178), with 82 neonates (age 
30 days). Periventricular leukomalacia was found in 44 of the neonates (54%)
compared with 1 of 23 infants (4%). Forward logistic regression using age at surgery
as a continuous variable identified a model containing longer total support time
(cardiopulmonary bypass plus deep hypothermic circulatory arrest), lower systolic
blood pressure at cardiac intensive care unit admission postoperatively, lower
minimum diastolic blood pressure, and PO2 in the first 48 hours after surgery. When
age at surgery was considered as a dichotomous variable (neonate versus infant),
younger age at surgery replaced systolic blood pressure, PO2, and total support time
in the model. Lower minimum diastolic blood pressure was a significant risk factor
in both models.
Conclusions: Periventricular leukomalacia was found in 50% of neonates after
cardiac surgery but rarely in older infants. Hypoxemia and hypotension in the early
postoperative period, particularly diastolic hypotension, may be important risk
factors for periventricular leukomalacia.
There has been a dramatic reduction in mortality following surgery forcomplex congenital heart defects in the past 2 decades. Unfortu-nately, there has also been increasing recognition of adverse neuro-developmental sequelae in some survivors.1-5 Evaluation of childrenfollowing neonatal repair of congenital heart disease (CHD) dem-onstrates a pattern of neurodevelopmental sequelae characterized by
mild cognitive impairment, speech and language abnormalities, impaired visual-
spatial and visual-motor skills, attention deficit/hyperactivity disorder (ADHD),
motor delays, as well as learning disabilities.3-5 Cerebral ischemia in the perioper-
ative period has been proposed to be a primary mechanism of central nervous
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system (CNS) injury.6 Management strategies during sur-
gery including type of support (deep hypothermic circula-
tory arrest [DHCA] or continuous cardiopulmonary bypass
[CPB]), hemodilution, degree of cooling, and blood gas
management have been implicated as factors in postopera-
tive neurodevelopmental dysfunction.1-6 However, there is
increasing evidence that CNS injury may also occur during
both the preoperative and postoperative periods.6 Neuroim-
aging and pathological studies suggest that cerebral white
matter injury characterized by periventricular leukomalacia
(PVL) is common in infants with CHD, especially after
surgery.7-9 The current study was undertaken to evaluate the
occurrence of PVL following cardiac surgery in neonates
and infants, as well as to evaluate potential risk factors.
Methods
Inclusion Criteria
A subgroup of children enrolled in a prospective study evaluating
polymorphisms of Apolipoprotein E (APOE) as a risk factor for
neurodevelopmental dysfunction also underwent early postopera-
tive (1-2 weeks) magnetic resonance imaging (MRI) of the brain.
Patients  6 months of age undergoing CPB, with or without
DHCA, for repair of CHD were eligible. Exclusion criteria in-
cluded (1) multiple congenital anomalies; (2) recognizable genetic
or phenotypic syndrome other than chromosome 22q11 microde-
letions; and (3) language other than English spoken in the home.
The study was approved by the Institutional Review Board at The
Children’s Hospital of Philadelphia. Informed consent was ob-
tained from the parent or guardian.
Operative Management
Surgery was performed by 4 cardiac surgeons with a dedicated
team of cardiac anesthesiologists. Alpha-stat blood gas manage-
ment was utilized. DHCA was utilized at the surgeon’s discretion.
Prior to DHCA, patients underwent core cooling with topical
hypothermia of the head to a nasopharyngeal temperature of 18°C.
Modified ultrafiltration was performed in all patients.
Data Collection
Data collected included gestational age, head circumference, birth
weight, and Apgar scores, which were obtained from birth records.
Weight and age at surgery and type of surgery were recorded,
along with CPB time, aortic crossclamp time, and duration of
DHCA. Total support time was calculated as CPB time plus
DHCA time. Postoperative hemodynamic data including heart rate
(HR), systolic blood pressure (SBP), diastolic blood pressure
(DBP), and right atrial pressure (RAP) were retrospectively re-
corded from the cardiac intensive care unit (CICU) flow sheet at
4-hour intervals for the first 48 hours postoperatively. Arterial
blood gas data including pH, PO2, and PCO2 were recorded at the
same intervals.
Postoperative MRI
MRI of the brain was performed in the early postoperative period
between 3 and 14 days after surgery. All patients were transported
to and from the MRI scanner, cared for, and, if necessary, sedated
and/or anesthetized by cardiac anesthesiologists for the MRI ex-
amination. No patient was intubated exclusively for MRI and all
patients recovered in the CICU.
MRI was performed with a 1.5 Tesla Magnetom magnet (Sie-
mens, Munich, Germany). T1- and T2-weighted images were
TABLE 1. Logistic regression of each predictor on PVL
separately
Predictors B Standard error P value
Preoperative factors
Apgar1 0.170 0.148 .251
Apgar5 0.343 0.317 .280
Birth head circumference
(%)
0.001 0.006 .895
Birth weight (%) 0.006 0.007 .389
APOE 22 or 23 0.396 0.740 .593
APOE 34 or 44 0.374 0.478 .435
Gestational age 0.144 0.097 .139
Gestational age (37, 37) 1.107 0.648 .087*
Diagnostic code n/a n/a .019*
Sex 0.298 0.402 .458
Operative factors
Age at surgery 0.031 0.011 .007*
Age at surgery (31, 31) 3.234 1.045 .002*
Weight 0.707 0.236 .003*
Operative class n/a n/a .003*
CPB 0.004 0.004 .383
DHCA (Y/N) 1.128 0.432 .009*
DHCA 0.024 0.009 .005*
Hematocrit 0.011 0.057 .840
Support 0.014 0.005 .009*
Surgeon n/a n/a .427
Postoperative factors
DBPadm 0.091 0.023 .000*
DBPmax 0.079 0.021 .000*
DBPmin 0.189 0.045 .000*
HRadm 0.007 0.008 .432
HRmax 0.004 0.007 .599
HRmin 0.028 0.013 .027*
PCO2adm 0.016 0.027 .557
PCO2max 0.028 0.028 .325
PCO2min 0.028 0.046 .540
pHadm 0.307 2.290 .893
pHmax 2.133 3.415 .532
pHmin 3.756 3.010 .212
PO2adm 0.002 0.001 .046*
PO2max 0.003 0.001 .023*
PO2min 0.048 0.016 .002*
RAPadm 0.026 0.051 .611
RAPmax 0.039 0.044 .379
RAPmin 0.015 0.107 .890
SBPadm 0.061 0.017 .000*
SBPmax 0.046 0.016 .003*
SBPmin 0.082 0.024 .001*
PVL, Periventricular leukomalacia; APOE, apolipoprotein E; CPB, cardio-
pulmonary bypass; DHCA, deep hypothermic circulatory arrest; DBP, dia-
stolic blood pressure; HR, heart rate; RAP, right atrial pressure; SBP,
systolic blood pressure; n/a, not applicable; adm, admission; max, maxi-
mum; min, minimum; B, regression coefficient.
*P  .10.
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TABLE 2. Correlation matrix of quantitative PVL predictors
Correlations Class
Gestational
age
Age at
surgery
Age at
surgery 2
Weight at
surgery
DHCA
(Y/N) DHCA
Support
time
Class
Pearson Correlation 1.000 .052 .335 .410 .176 .605 .647 .033
P (2-tailed) .599 .001* .001* .073 .001* .001* .737
n 105 105 105 105 105 105 105 105
Gestational age
Pearson Correlation .052 1.000 .056 .027 .304 .103 .054 .153
P (2-tailed) .599 .570 .785 .002* .294 .585 .119
n 105 105 105 105 105 105 105 105
Age at surgery
Pearson Correlation .335 .056 1.000 .861 .763 .413 .382 .243
P (2-tailed) .001* .570 .001* .001* .001* .001* .013*
n 105 105 105 105 105 105 105 105
Age at surgery 2
Pearson Correlation .410 .027 .861 1.000 .630 .378 .398 .332
P (2-tailed) .001* .785 .001* .001* .001* .001* .001*
n 105 105 105 105 105 105 105 105
Weight at surgery
Pearson Correlation .176 .304 .763 .630 1.000 .458 .321 .113
P (2-tailed) .073 .002* .001* .001* .001* .001* .252
n 105 105 105 105 105 105 105 105
DHCA (Y/N)
Pearson Correlation .605 .103 .413 .378 .458 1.000 .777 .049
P (2-tailed) .001* .294 .001* .001* .001* .001* .621
n 105 105 105 105 105 105 105 105
DHCA
Pearson Correlation .647 .054 .382 .398 .321 .777 1.000 .142
P (2-tailed) .001* .585 .001* .001* .001* .001* .149
n 105 105 105 105 105 105 105 105
Support
Pearson Correlation .033 .153 .243 .332 .113 .049 .142 1.000
P (2-tailed) .737 .119 .013* .001* .252 .621 .149
n 105 105 105 105 105 105 105 105
DBPadm
Pearson Correlation .516 .173 .391 .437 .310 .329 .404 .036
P (2-tailed) .001* .077 .001* .001* .001* .001* .001* .715
n 105 105 105 105 105 105 105 105
DBPmax
Pearson Correlation .595 .116 .613 .598 .549 .497 .508 .146
P (2-tailed) .001* .238 .001* .001* .001* .001* .001* .136
n 105 105 105 105 105 105 105 105
DBPmin
Pearson Correlation .453 .216 .469 .489 .545 .388 .359 .095
P (2-tailed) .001* .027* .001* .001* .001* .001* .001* .334
n 105 105 105 105 105 105 105 105
HRmin
Pearson Correlation .398 .009 .327 .318 .240 .377 .323 .118
P (2-tailed) .001* .924 .001* .001* .014* .001* .001* .231
n 105 105 105 105 105 105 105 105
PO2adm
Pearson Correlation .617 .122 .185 .290 .091 .268 .320 .109
P (2-tailed) .001* .216 .059 .003* .356 .006* .001* .267
n 105 105 105 105 105 105 105 105
PO2max
Pearson Correlation .655 .078 .181 .273 .064 .255 .309 .120
P (2-tailed) .001* .430 .065 .005* .517 .009* .001* .224
n 105 105 105 105 105 105 105 105
PO2min
Pearson Correlation .628 .007 .332 .380 .165 .228 .423 .104
P (2-tailed) .001* .944 .001* .001* .093 .019* .001* .291
n 105 105 105 105 105 105 105 105
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DBPadm DBPmax DBPmin HRmin PO2adm PO2max PO2min SBPadm SBPmax SBPmin
.516 .595 .453 .398 .617 .655 .628 .234 .144 .028
.001* .001* .001* .001* .001* .001* .001* .017* .143 .776
105 105 105 105 105 105 105 105 105 105
.173 .116 .216 .009 .122 .078 .007 .196 .017 .047
.077 .238 .027 .924 .216 .430 .944 .045* .862 .636
105 105 105 105 105 105 105 105 105 105
.391 .613 .469 .327 .185 .181 .332 .385 .514 .588
.001* .001* .001* .001* .059 .065 .001* .001* .001* .001*
105 105 105 105 105 105 105 105 105 105
.437 .598 .489 .318 .290 .273 .380 .447 .482 .524
.001* .001* .001* .001* .003* .005* .001* .001* .001* .001*
105 105 105 105 105 105 105 105 105 105
.310 .549 .545 .240 .091 .064 .165 .266 .377 .564
.001* .001* .001* .014* .356 .517 .093 .006* .001* .001*
105 105 105 105 105 105 105 105 105 105
.329 .497 .388 .377 .268 .255 .228 .191 .166 .253
.001* .001* .001* .001* .006* .009* .019* .051 .091 .009*
105 105 105 105 105 105 105 105 105 105
.404 .508 .359 .323 .320 .309 .423 .201 .181 .179
.001* .001* .001* .001* .001* .001* .001* .040* .065 .067
105 105 105 105 105 105 105 105 105 105
.036 .146 .095 .118 .109 .120 .104 .108 .288 .365
.715 .136 .334 .231 .267 .224 .291 .271 .003 .001*
105 105 105 105 105 105 105 105 105 105
1.000 .719 .636 .204 .407 .404 .370 .673 .372 .167
.001* .001* .037 .001* .001* .001* .001* .001* .088
105 105 105 105 105 105 105 105 105 105
.719 1.000 .673 .346 .399 .409 .347 .443 .546 .349
.001* .001* .001* .001* .001* .001* .001* .001* .001*
105 105 105 105 105 105 105 105 105 105
.636 .673 1.000 .209 .317 .300 .353 .361 .314 .429
.001* .001* .032* .001* .002* .001* .001* .001* .001*
105 105 105 105 105 105 105 105 105 105
.204 .346 .209 1.000 .182 .218 .122 .186 .190 .165
.037* .001* .032* .063 .025* .216 .058 .052 .093
105 105 105 105 105 105 105 105 105 105
.407 .399 .317 .182 1.000 .973 .617 .218 .099 .087
.001* .001* .001* .063 .001* .001* .025* .313 .378
105 105 105 105 105 105 105 105 105 105
.404 .409 .300 .218 .973 1.000 .600 .218 .099 .099
.001* .001* .002* .025* .001* .001* .026* .315 .315
105 105 105 105 105 105 105 105 105 105
.370 .347 .353 .122 .617 .600 1.000 .214 .072 .076
.001* .001* .001* .216 .001* .001* .028 .465 .442
105 105 105 105 105 105 105 105 105 105
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performed in the axial plane, with T1 imaging also acquired in the
sagittal and coronal planes. A gradient echo T2 axial scan was
done for the susceptibility effects of blood products. All MRIs
were reviewed and interpreted by a single neuroradiologist
(R.A.Z.), using a scoring system for localizing and grading cere-
bral injury developed for this project. Most PVL is seen in this
population as areas of increased signal intensity on T1-weighted
images in the periventricular white matter. Small punctate areas (1
or more) of increased T1 signal (less than 3 mm) were classified as
mild PVL. These usually occur in the frontal and parietal regions
and may be bilateral. When there were multiple small areas of
increased T1 signal, between 3 mm and 1 cm in size, the PVL was
classified as moderate. These may be bilateral in the frontal,
parietal, and temporal regions but are not confluent. Larger con-
fluent areas with plaques greater than 1 cm, often bilateral, in the
frontal, parietal, and sometimes temporal regions were classified as
severe PVL.
APOE Genotype Determination
Whole blood was obtained prior to surgery and stored at 4°C.
Genomic DNA was prepared and used to determine APOE geno-
types utilizing a previously published method.10
Data Analysis
Patients were coded according to a previously described classifi-
cation incorporating cardiac anatomy and perioperative physiol-
ogy, which has been shown to be predictive of perioperative
mortality.11 Class I is 2 ventricles with no aortic arch obstruction;
class II is 2 ventricles with aortic arch obstruction; class III is
single ventricle with no arch obstruction; and class IV is single
ventricle with arch obstruction. Patients with tetralogy of Fallot
(TOF) and transposition of the great arteries (TGA) are class I,
while patients with hypoplastic left heart syndrome (HLHS) or
variants are class IV. Patients were also grouped according to
specific cardiac diagnoses: patients with HLHS; patients with
conotruncal defects (TOF, TGA, truncus arteriosus, etc); and all
other defects.
Statistical Methods
Data are presented as median and range, where appropriate. All
predictors of PVL considered are listed in Table 1. Monitoring data
(PO2, PCO2, pH, SBP, DBP, RAP, HR) had repeated measures from
time zero (CICU admission) to 48 hours taken at 4-hour intervals.
For each of these monitoring variables, the minimum and maxi-
mum values during the study period were identified and only time
zero, minimum, and maximum values were considered. For SBP,
for example, the variables SBPadm, SBPmin, and SBPmax were
considered. Three quantitative predictors were also dichotomized:
gestational age (gestational age 2) was grouped as premature (less
than 37 weeks) or not (37 weeks); age at surgery (age at surgery
2) was grouped as neonate (up to 30 days of age) or not (31 days
of age or older); and use of DHCA was grouped as “yes” or “no.”
All predictors listed in Table 1 were tested by logistic regres-
sion for univariate prediction of PVL. Presence of PVL was coded
as 1, absence as 0. Dichotomous variables were treated as 0, 1
dummy variables. APOE genotype was grouped into 3 groups: the
2 group (22 and 23), the 33 group, and the 4 group (34
and 44). Because of the opposing effects of 2 and 4 in
Alzheimer’s disease, patients with 24 were excluded. These
were then considered as 2 dummy variables (2 vs 3 and 4 vs
3). Any predictor of PVL that was found to have a P value of .1
or less was considered in a forward stepwise logistic regression to
determine a model for prediction of PVL. Gestational age and age
at surgery were coded as both continuous and dichotomous in
separate regressions. Use of DHCA was also considered separately
from the quantitative variable length of DHCA use. The relation-
ship of all quantitative variables in the final model for PVL
prediction was plotted. The correlation structure of all predictive
variables was also evaluated. All analyses used SPSS 10.0 for
Windows.
Results
Between June 21, 2000, and November 5, 2001, 206 eligible
infants underwent cardiac surgery. Of these 169 (82%)
enrolled in the study of APOE genotype and 105 of the
TABLE 2. Correlation matrix of quantitative PVL predictors
Correlations Class
Gestational
age
Age at
surgery
Age at
surgery 2
Weight at
surgery
DHCA
(Y/N) DHCA
Support
time
SBPadm
Pearson Correlation .234 .196 .385 .447 .266 .191 .201 .108
P (2-tailed) .017* .045 .001* .001* .006* .051 .040* .271
n 105 105 105 105 105 105 105 105
SBPmax
Pearson Correlation .144 .017 .514 .482 .377 .166 .181 .288
P (2-tailed) .143 .862 .001* .001* .001* .091 .065 .003*
n 105 105 105 105 105 105 105 105
SBPmin
Pearson Correlation .028 .047 .588 .524 .564 .253 .179 .365
P (2-tailed) .776 .636 .001* .001* .001* .009* .067 .001*
n 105 105 105 105 105 105 105 105
Surgery for Congenital Heart Disease Galli et al
696 The Journal of Thoracic and Cardiovascular Surgery ● March 2004
CH
D
enrolled patients (62%) underwent postoperative MRI.
Seven of the 169 patients enrolled in the larger study (4.1%)
died prior to hospital discharge. All patients enrolled in the
APOE study were approached for enrollment in the MRI
study. Reasons for not undergoing MRI included discharge
prior to MRI, instability precluding MRI prior to 14 days,
and parental preference. Seventeen patients also partici-
pated in a simultaneous pre- and postoperative MRI study.
There were 44 girls and 61 boys. The median gestational
age was 39 weeks (range 28-42) with a median birth weight
of 3125 g (range 739-4528). Twelve patients (11%) were
younger than 37 weeks gestational age. The median head
circumference at birth was 34 cm (range 24-38, n  103).
Microcephaly (birth head circumference less than fifth per-
centile for gestational age) was present in 17% of the
patients.
The median age at surgery was 6 days (range 1-178).
Eighty-two patients underwent surgery as neonates. Median
weight at surgery was 3.4 kg (range 1.5-6.9). Forty-four
patients were class I, 11 were class II, 9 were class III, and
41 were class IV. HLHS was present in 33 infants,
conotruncal defects in 51, and other defects in 21. DHCA
was utilized in 64 patients with a median duration of 38
minutes (range 1-86). Median cooling time prior to DHCA
was 15 minutes (range 8-35). Only 2 patients were cooled
for less than 15 minutes. The median total support time was
88 minutes (range 13-242). The median hematocrit after
hemodilution on CPB was 27% (range 20-37).
APOE genotype was completed for 98 of 105 patients
(93%). Eight were 22 or 23 and 26 were 34 or 44.
The 33 genotype was present in 61 patients. There were 3
patients with 24.
The median postoperative day for performance of MRI
was 7 (range 3-14). PVL was identified in 45 infants (43%;
Figure 1). PVL was identified in 44 of 82 neonates (54%)
compared with only 1 of 23 (4%) older infants. The severity
of PVL was mild in 36 of 45 (80%), moderate in 8 (18%),
and severe in 1 (2%). The PVL was unilateral in 16 of 45
(36%) and bilateral in 29 (64%). PVL was identified in 25%
of class I patients, 36% of class II patients, 33% of class III
patients, and 60% of class IV patients.
Table 1 lists all potential predictors of PVL considered
and shows the regression coefficients as well as the univar-
iate statistical significance. A positive regression coefficient
suggests that the variable is positively correlated with PVL.
All variables that predicted PVL at a P  .1 level were
examined for their correlations. As expected, many of these
variables are highly correlated (Table 2). Gestational age
did not remain in the final model, regardless of whether it
was quantitative or qualitative; however, the coding of age
at surgery (dichotomous vs continuous) did affect the final
model. In addition, no APOE genotype effect on the risk of
PVL was identified. Forward logistic regression considering
age at surgery as a quantitative variable identified a model
containing the minimum DBP (DBPmin) and PO2 (PO2min),
the SBP at CICU admission (SBPadm), and longer total
support time as significant predictors of PVL (Table 3). It is
important to note that given the highly correlated nature of
the other predictors, this may not be the only useful predic-
tive model for this set of risk factors. However, given these
variables, none of the other predictors improved prediction
of PVL. The direction of these effects was as expected:
lower DBPmin, lower PO2min, and lower SBPadm all in-
creased risk of PVL, as did longer total support time. To aid
in the visualization of the relationship of these 4 variables
with PVL, the subjects were grouped according to the
predictor and the proportion of subjects in each group with
PVL plotted (Figure 2). However, when age at surgery was
dichotomized (30 days or 30 days), it remained in the
final model (Table 3), replacing PO2min, SBPadm, and total
DBPmax DBPmin HRmin PO2adm PO2max PO2min SBPadm SBPmax SBPmin
.443 .361 .186 .218 .218 .214 1.000 .656 .374
.001* .001* .058 .025* .026* .028* .001* .001*
105 105 105 105 105 105 105 105 105
.546 .314 .190 .099 .099 .072 .656 1.000 .603
.001* .001* .052 .313 .315 .465 .001* .001*
105 105 105 105 105 105 105 105 105
.349 .429 .165 .087 .099 .076 .374 .603 1.000
.001* .001* .093 .378 .315 .442 .001* .001*
105 105 105 105 105 105 105 105 105
PVL, Periventricular leukomalacia; DHCA, deep hypothermic circulatory arrest; DBP, diastolic blood pressure; HR, heart rate; SBP, systolic blood pressure;
adm, admission; max, maximum; min, minimum.
*P  .05.
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support time as significant predictors of PVL. When the
analysis was restricted to the 82 neonates, DBPmin and
SBPadm remained significant predictors of PVL in the mul-
tivariable analysis with age at surgery considered as a
continuous variable. PO2min and longer total support time
were no longer significant.
Discussion
This study demonstrates that PVL is a frequent finding on
MRI of the brain following cardiac surgery in neonates. The
occurrence of PVL is much less common in older infants.
Prolonged exposure to CPB (with or without DHCA) is a
risk factor for PVL, possibly secondary to the systemic
inflammatory response to CPB. Hypotension and hypox-
emia in the early postoperative period, especially diastolic
hypotension, significantly increase the risk of PVL, possibly
secondary to cerebral ischemia. In infants without CHD,
PVL is associated with developmental dysfunction includ-
ing impaired motor function, learning disabilities, and
ADHD. The significance of PVL identified on an early
postoperative MRI as a predictor of a long-term neurode-
velopmental outcome must be determined.
PVL was described as a specific entity in 1962 by the
neuropathologic studies of Banker and Larroche.12 PVL is
defined by the presence of focal necrosis of all cellular
elements in the deep white matter surrounding the walls of
the lateral ventricles and a more diffuse injury to oligoden-
droglial precursors.13-16 PVL was recognized initially as a
pathologic condition relatively specific to the preterm neo-
nate; however, appreciation of its clinical significance was
overshadowed by its common coexistence with more dra-
matic-appearing lesions such as germinal matrix, intraven-
tricular, and parenchymal hemorrhages. Cranial ultrasonog-
raphy has demonstrated that PVL may be detected in 7% to
26% of preterm infants. PVL in preterm infants is highly
associated with subsequent cerebral palsy, mental retarda-
tion, learning disabilities, visual-motor deficits, and
ADHD.13-16 PVL may be encountered in the term infant
following significant asphyxia, hypoglycemia, meningitis,
CHD, and other conditions.17 The late consequences of
PVL in term infants without CHD are comparable to those
in prematurity and resemble the long-term neurodevelop-
mental “signature” of some children following surgical re-
pair of CHD.17
One of the key developmental processes in premature
and very young infant is progression of myelination, in
which precursors of myelin are created, mature, and even-
tually envelop axons in the cerebral hemispheres, cerebel-
lum, brain stem, and spinal cord. There is an age-dependent
window of vulnerability to injury of developing white mat-
ter. PVL is one of the hallmarks of brain injury in premature
and some term infants but is much less common thereafter.
The target for diffuse white matter injury in PVL is the early
differentiating oligodendrocyte, histologically distinguished
from its mature counterpart by the absence of myelin basic
protein staining.16 Whereas mature oligodendroglia are rel-
atively resistant to injury from conditions such as hypoxia-
ischemia, differentiating oligodendrocytes are exquisitely
sensitive to a variety of insults, including hypoxia, isch-
emia, reactive oxygen species, and inflammatory media-
Figure 1. A, Axial MRI image (T1-weighted) demonstrating 2 small areas of increased signal intensity in the
periventricular white matter consistent with PVL, classified as mild (arrows). B, Axial MRI image (T1-weighted)
demonstrating multiple larger areas of increased signal density in the periventricular white matter consistent with
PVL, classified as moderate (arrows).
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tors.13-16,18 In addition to direct toxic effects, oligodendro-
cyte maturation may be disrupted. Clinical conditions in
preterm infants that result in cerebral ischemia, such as
respiratory distress syndrome, patent ductus arteriosus, hy-
potension, and impaired autoregulation of cerebral blood
flow, are associated with the development of PVL. Previous
studies have also suggested that hyperventilation producing
hypocarbia is a risk factor for PVL, possibly secondary to
alteration in cerebral blood flow resulting in cerebral isch-
emia.19 Hypocarbia was not identified as a risk factor in our
study.
Cytokine networks play important roles in normal brain
development. However, in some pathologic conditions, cy-
tokines [such as tumor necrosis factor- (TNF-) and in-
terleukin-6 (IL-6)] may be directly toxic to vulnerable,
immature oligodendroglia while others are indirectly toxic
through glial stimulation of nitric oxide, reactive oxygen
species, and excitatory amino acids.13-16,18 There is in vitro
evidence that IL-6 may alter the developmental pathways of
oligodendrocyte precursors away from myelinating oligo-
dendrocytes toward astrocyte development. There is in-
creasing evidence that the systemic inflammatory response
of the fetus and neonate is an important mechanism of white
matter injury.13-16 The role of the systemic inflammatory
response induced by CPB as a mediator of white matter
injury is not known.
Children with CHD are at risk for cerebral hypoperfusion
and hypoxemia before, during, and after cardiac surgery.6
Use of DHCA results in a period of global cerebral isch-
emia. Postoperative hemodynamic instability with low car-
diac output and hypotension may also decrease cerebral
perfusion. Many infants are hypoxemic before and after
reconstructive surgery. In addition, use of CPB for the
repair of CHD initiates a systemic inflammatory response.6
Exposure of blood to the foreign surface of the bypass
circuit results in activation of complement as well as acti-
vation of the coagulation and fibrinolytic pathways. The
systemic inflammatory response includes cytokine produc-
tion, neutrophil activation, and endothelial cell activation.
Dramatic increases of circulating cytokines for 24 to 48
hours have been reported in many studies of patients un-
dergoing CPB including TNF- and IL-6, as well as other
cytokines.
These potential risk factors do not fully explain the
frequency or pattern of neurodevelopmental dysfunction.
There is significant interindividual variation in developmen-
tal outcome, even among children with the same cardiac
defect, suggesting that other patient-specific factors may be
important determinants of CNS injury. In a recent study we
demonstrated that APOE genotype, specifically the APOE
2 allele, was predictive of a worse neurodevelopmental
outcome at 1 year of age following neonatal and infant
cardiac surgery.20 In the current study we were unable to
demonstrate an effect of APOE genotype as a predictor of
PVL. However, given the relatively small size of the study
population and the rarity of the APOE 2 allele (approxi-
mately 8% of the population), the statistical power to dem-
onstrate a genotype effect is very limited.
Prior neuropathology and autopsy studies have demon-
strated that PVL is a common finding in patients with CHD.
A study of 33 children with CHD who were older than 1
year of age at death demonstrated white matter injury in
75% of the brains examined postmortem.7 A neuropatho-
logic study conducted at our institution examined expired
infants with HLHS.8 Both congenital and acquired abnor-
malities were demonstrated. The most common acquired
ischemic neuropathologic lesions were PVL, present in over
25% of those examined, and localized strokes.
A recent study at our institution utilizing serial MRIs
(preoperative, early postoperative, and late postoperative) in
24 patients demonstrated that PVL is common early after
neonatal cardiac surgery (50% of neonates), consistent with
another study.21 Interestingly, PVL was present in 16% of
the infants preoperatively, suggesting that in utero or early
postnatal CNS injury had occurred. However, over 50% of
the infants demonstrated new or worsened PVL on the early
postoperative MRI consistent with CNS injury occurring in
the intraoperative and early postoperative periods. How-
ever, PVL could no longer be demonstrated 3 to 6 months
after surgery. This apparent resolution of PVL does not
imply that white matter injury did not occur, but rather that
more sensitive imaging techniques may be necessary after
resolution of the acute injury. Few other studies have eval-
uated infants with brain MRI following cardiac surgery,
especially in the early postoperative period. Miller and
associates9 evaluated MRI of the brain in 23 children who
had undergone cardiac surgery. MRI was performed at least
2 years following cardiac surgery. Ten patients had under-
gone neonatal cardiac surgery. White matter injury was
demonstrated in 10 of 23 patients (43%) and in 8 of 10
(80%) of patients who had undergone neonatal heart sur-
TABLE 3. Forward stepwise logistic regression results
when age at surgery is considered as continuous (model 1)
and dichotomous (model 2)
Predictors B
Standard
error P value
Model 1
DBPmin 0.141 0.050 .005
PO2min 0.051 0.019 .008
SBPadm 0.039 0.020 .045
Support time 0.020 0.007 .005
Model 2
DBPmin 0.146 0.470 .002
Age at surgery 2 2.433 1.076 .024
DBP, Diastolic blood pressure; SBP, systolic blood pressure; B, regression
coefficient.
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gery. At the 1-year follow-up evaluation of the Boston
Circulatory Arrest Study, MRI of the brain was performed
in 142 children.2 Definite abnormalities were present in 22
patients (15%) and possible abnormalities in 11 (8%). PVL
was not reported. In this study the prevalence of an MRI
abnormality was related to preoperative acidosis but not to
use or duration of DHCA.
There are several limitations to the current study. There
is a possibility of selection bias, as not all parents of
enrolled patients consented to the MRI.21 Some potential
patients were discharged before the MRI could be obtained
and others were deemed unstable to undergo MRI until after
the study period, thus both well and ill children were ex-
cluded. Preoperative MRI was not performed; therefore, it is
possible PVL was present in some patients prior to surgery.
In the study by Mahle and associates,21 however, PVL was
present in only 16% of patients prior to surgery and new or
worsened PVL was found in 52% of patients on the early
postoperative MRI. This suggests that the white matter
injury most commonly occurs intraoperatively or during the
early postoperative period. In addition, because PVL is an
evolving lesion the time variability in the performance of
the postoperative study may result in an underestimation of
the incidence. Serial imaging studies may be necessary.
Finally, many of the variables were highly correlated as
expected (Table 2). There might be other useful risk models
based on other predictors; however, none of the available
predictors improved the occurrence of PVL.
Figure 2. A, Relationship between total support time (CPB  DHCA) and the occurrence of PVL. Patients are
grouped according to total support time in 30-minute intervals. The percentage of patients in each group having
PVL is shown on the y-axis. B, Relationship between systolic blood pressure on admission to the CICU
postoperatively and occurrence of PVL. Patients are grouped according to the systolic blood pressure initially
obtained at CICU admission in increments of 10 mm Hg. The percentage of patients with PVL is shown on the y-axis.
Surgery for Congenital Heart Disease Galli et al
700 The Journal of Thoracic and Cardiovascular Surgery ● March 2004
CH
D
In conclusion, this study demonstrates that cerebral white
matter injury manifested as PVL is found in more than 50%
of neonates early following cardiac surgery but is rare in
older infants. Prolonged exposure to CPB (with or without
DHCA) and hypoxia and hypotension in the early postop-
erative period were associated with PVL in this population.
Future studies are necessary to determine the long-term
significance of PVL identified on early postoperative MRI
as a marker for long-term neurodevelopmental function in
these patients. Future clinical neuroprotection trials and
outcome studies should include CNS imaging and detailed
collection of preoperative, intraoperative, and postoperative
hemodynamic variables, as these may yield important in-
sights into the mechanisms of CNS injury in children with
CHD
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Discussion
Dr Ross M. Ungerleider (Portland, Ore). You have nicely em-
phasized the importance of preoperative and postoperative ele-
ments in affecting neurologic outcomes, and this is the rationale
behind so many evolving management strategies for neonates
before and after surgery. We need to examine outcomes over time
to see if neurologic outcomes improve, despite our very aggressive
approach to neonatal cardiac repair, but it is my impression that
neurologic outcomes in general are improving.
I do have the following questions for you. First, if you could
please tell us a little bit more about periventricular leukomalacia.
Is it specific for certain kinds of injury and outcome, or is it a
general MRI finding that can have many causes and correlate with
variable outcomes?
Second, have you looked for PVL in neonates without cardiac
disease, specifically those who are hypoxemic, such as with lung
disease, or those who have diastolic hypotension, such as those
who have sepsis, as opposed to just all the neonates in general who
are not cardiac patients? Can you see if that break point of yours
is even more notable in those patients who are hypoxemic or
hypotensive? In patients with postoperative hypoxemia (a PO2 of
less than 40) or postoperative hypotension (a diastolic blood pres-
sure less than 35), both of which were break points in your study,
was there a correlation when this occurred in the postoperative
period and the likelihood of PVL? That is, is hypoxemia or
hypotension worse from the standpoint of leading to or being
associated with PVL if it occurs in the first 2 days after surgery
rather than if it occurs on postoperative day 4, for example?
It is interesting that you include the CPB period, since all of the
patients in your study had some episode of hypotension. If you
consider that there was a mean blood pressure lower than the
diastolic pressure break point on CPB for most of these patients,
was there any correlation between mean blood pressure on pump
and PVL?
Can you tell us anything more about the follow-up correlation
of PVL in your study patients and their neurologic outcomes?
Obviously that’s going to be very critical to knowing the impor-
tance of this study.
And finally, the implication of this study is that in our zeal to
operate on neonates, we may be subjecting them to risks for
neuroneural behavioral outcomes that might be different if we
could wait until they were outside the neonatal period. Alterna-
tively, it may simply be that neonates who require cardiac repair
have an inherent risk for adverse neurologic outcome. It would be
interesting if you could reexamine your data in a manner that could
help us understand that. For example, is there a difference between
babies with a single diagnosis such as TOF with respect to their
association with PVL related to the timing of operation?
Dr Gaynor. Thank you very much, Dr Ungerleider. I will try
to go through your questions.
PVL represents cerebral white matter injury, that is, axonal
injury, oligodendrocyte injury. PVL specifically affects the white
matter tracts and that has been confirmed in pathologic studies.
There is some unpublished data from our institution comparing
MRI findings with the pathologic findings in a small group of
infants who died. Our radiologists and neuropathologists have
demonstrated that these MRI findings are specific for PVL. So it is
not really a general MRI finding. It is specific for white matter
injury and correlates with injury to the white matter tracts. There
is often subsequent delayed myelination. The findings seen on
early MRI may be related to the edema and other changes asso-
ciated with early cell injury; therefore, later MRIs may not show
white matter injury. You see loss of volume, with increased
ventricles and decreased brain volume, suggesting white matter
loss, but the acute effects of edema have all resolved.
We haven’t looked for PVL in neonates without cardiac dis-
ease, but the patient population in which PVL was described is in
the neonatal intensive care unit, in the preterm infants, and it has
been associated with a variety of factors, with hypoxemia, with
respiratory distress syndrome in these infants, and with hypoten-
sion. So these are risk factors in the neonatal patient without
cardiac disease, but most of those studies have been done in
preterm infants.
Regarding the break points, we didn’t specifically look for
break points. We were just looking at the graphs. It does look like
there are break points, particularly for the PO2 and the diastolic
blood pressure.
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We don’t know whether intervention to improve oxygenation
or raise the blood pressure would prevent PVL. That’s obviously
the next study. I don’t think you can make that leap from this
study, that if we can avoid hypoxemia of less than 40 and a
diastolic blood pressure of less than 35 we will prevent PVL, but
I think that could be an important hypothesis for future studies.
And I do think that the timing of the occurrence of hypoxemia
and hypotension probably is very important. The early postoper-
ative period after an episode of bypass or a period of deep hypo-
thermic circulatory arrest, or even if the children had been sick
preoperatively, is a vulnerable period that even if you had not
irreversibly injured neurons or the oligodendrocytes, an additional
insult in that early postoperative period results in neuronal death.
So I think if you are further past surgery, you may be less
vulnerable to injury. Again, that will need to be tested.
We did not look at the mean pressures on bypass. That would
be an interesting future study.
These infants have come back for neurodevelopmental evalu-
ation at 1 year of age, assessed with a neurologic exam and the
Bailey’s scales of infant development, but we haven’t analyzed the
data yet. That hopefully will be a future presentation.
As far as the implications regarding the elective neonatal sur-
gery, when we looked at the distribution in the first month of life,
it was pretty much even, whether it was week 1, 2, 3, or 4, and the
real break point occurred at about 30 days. Now, I don’t know if
it is colinear with cardiac diagnosis (the reason the children are
having the surgery) or whether it is related to the physiology and
the maturation of the oligodendrocytes.
I think it would be interesting to study in the future whether or
not it’s better to operate on patients with TOF when they are 1
week old if they are asymptomatic or if it’s better to wait until they
are 2 months old, taking risk of increasing cyanosis. But I think we
should consider that operating on neonates who may be vulnerable
simply because we feel it is better to do this in the neonatal period
may not always for every child be the best option.
Dr James S. Tweddell (Milwaukee, Wis). My question really
involves the finding of decreased diastolic pressure as a risk factor.
Obviously pressure is dependent on the systemic vascular resis-
tance and total cardiac output, or cardiac output. I was wondering
if you could give us any insight into which of those 2 factors seem
to have the most impact on the development of PVL, or if you are
able to sort that out at all? Really, it relates to whether a patient
with good cardiac output and a low diastolic pressure is at greater
risk as a patient whose diastolic hypotension is due primarily to
low output.
Dr Gaynor. Well, we weren’t able to evaluate that in the study,
but I think that’s a very interesting question. What controls cere-
bral blood flow in the early postoperative period, and how is the
blood flow distributed through the body? Is it systemic vascular
resistance? Is it cerebrovascular resistance? I know you are going
to present some data later on looking at that. I’m sure total cardiac
output is important. One of the really important messages of this
article is that the early postoperative period is a time of risk for
these children. We have focused so much on what we do in the
operating room and the use versus nonuse of DHCA that we
sometimes do not consider the intensive care unit. We have to
concentrate on protecting the brain in the early postoperative
period. We need to do studies where we actually assess the
adequacy of cerebral blood flow, either looking at cerebral oxy-
genation or some measure of cerebral blood flow, and then deter-
mine whether an intervention that will increase blood pressure by
increasing systemic vascular resistance will improve cerebral
blood flow. Alternatively we can try to increase cardiac output and
hope that the flow distribution will improve cerebral blood flow.
I think that’s something we really need to begin to look at. We
are not able to answer that from that study, but I think this is
something that is clearly important as we go forward.
Dr Glen Van Arsdell (Toronto, Ontario, Canada). That was a
beautiful presentation and study and has some important implica-
tions for us, and you’ve alluded to some. I wanted to just see
whether I could get you to further delineate how you analyzed this.
Obviously, one of the simmering debates is the timing of repair
in certain lesions, and the Boston neurologic outcome data have
suggested that if you have prolonged intubation, it may well affect
your long-term neurologic outcome. Have you tried to correlate the
2 factors, time of intubation and age at repair, to see whether or not
that had any impact on PVL? And second, have you looked at a
continuous variable to preoperative oxygen saturation and whether
or not that had any impact on PVL?
Dr Gaynor. We haven’t looked at those factors specifically.
We did do a study with Dean Kurth, who is now at Cincinnati,
using near-infrared spectroscopy to look at cerebral oxygenation
preoperatively. In some subgroups, particularly patients with hy-
poplastic left heart syndrome, it can be dangerously low in the
preoperative period. That was not measured in this study, and this
does not occur in every infant. Some of these children were infants
who came in for elective surgery.
But I think it is important to focus on the preoperative period,
the potential for injury in the preoperative period. How we are
setting these patients up for surgery? Can we optimize their con-
dition, their cerebral blood flow, in the preoperative period, so
perhaps they are less vulnerable for the operative period?
In our previous study, the incidence of PVL prior to surgery or
at the time of surgery is fairly low, 16%, compared with approx-
imately 50% postoperatively. So I think most of the injury is
occurring either intraoperatively or in the early postoperative pe-
riod. But we may be setting kids up. If we take a patient who has
dangerously low cerebral oxygenation to the operating room, he
may be more vulnerable than another child.
We did not look at duration of ventilation. I don’t know that the
problem is the duration of ventilation per se, it may be, or is it just
a surrogate for some other marker of illness, or if there is some
other problem going on. I don’t know. We didn’t look at that in
these data. We could go back and look at that, but we haven’t thus
far.
Dr Frank L. Hanley (Stanford, Calif). The most dramatic
finding you showed, Bill, was the difference in the insult between
neonates and nonneonates. On initial assessment of these findings,
it seems clear that that there is either something very different in
the way neonates and relatively young infants respond or there is
something different in your management techniques between ne-
onates and nonneonates. One or both of these may be very impor-
tant here. The similarities and differences in the management
schemes of these 2 groups were not presented. Can you review
whether you use different bypass techniques, hematocrits, or other
factors when treating neonates as compared with older infants that
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could give us some insights into the overall management differ-
ences during and shortly after bypass between the 2 groups?
Dr Gaynor. The management strategies and the bypass strat-
egies are fairly similar. The older children probably have a lower
incidence of deep hypothermic circulatory arrest, but obviously the
neonate state is colinked to many other variables, particularly
diagnosis. The patients with HLHS were all neonates. That means
the neonates had a greater incidence of the use of circulatory arrest.
So there may be some colinking there, and these other factors are
important. But there are also physiologic differences in the neo-
natal brain. The oligodendrocytes are not fully mature at birth.
There is a maturation period that occurs after birth; it may be that
the oligodendrocytes in the neonate are more vulnerable to injury
than those of the older infants. I think there are a lot of things that
are related, and we need to sort out what those factors are.
Dr Hanley. Can you give us just a very brief overview
of when you did not use DHCA? What was the standard
so-called “continuous bypass management,” in terms of did you
go low flow, how low, for how long a period of time, things like
that?
Dr Gaynor. That again, we would have to go back and look
at it specifically because it is highly variable between the
surgeons doing the cases. Some of these children were 6 months
old who underwent ventricular septal defect closure and had
continuous bypass at full flow with mild to moderate hypother-
mia; others were neonates who had fairly deep hypothermia and
low flow bypass for a period of time. We haven’t broken that out
in terms of the specific bypass strategies. That is something we could
look at, but it is not a uniform technique for this study and wasn’t
controlled as a factor for this study.
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